Skip to main content
Top
Published in: Drugs 8/2003

01-04-2003 | Therapy In Practice

Postoperative Analgesia and Sedation in the Adult Intensive Care Unit

A Guide to Drug Selection

Authors: Assistant Clinical Professor Linda L. Liu, Michael A. Gropper

Published in: Drugs | Issue 8/2003

Login to get access

Abstract

An essential goal of all critical care physicians should be to maintain an optimal level of pain control and sedation for their patients. This has become increasingly important because of evidence showing that the combined use of sedatives and analgesics may ameliorate the detrimental stress response in critically ill patients. Unfortunately, both pain and anxiety are subjective and difficult to measure, thereby limiting our ability to analyse these states and making management more challenging.
Although there is still a lack of high quality, randomised, prospective, controlled trials comparing agents, monitoring techniques and scoring scales, several societies have come together to publish some clinical practice guidelines for sedation and analgesia. Recommended opioids are fentanyl or hydromorphone for short-term use, and morphine or hydromorphone for longer-term therapy. Midazolam or diazepam are recommended for sedation of the acutely agitated patient, while lorazepam is recommended for longer infusions. Propofol is preferred when rapid awakening is desired.
The challenge for critical care physicians is to use these medications to provide comfort and safety without increasing morbidity or mortality. Most studies support the use of protocols in order to help achieve these goals. The bottom line is that most protocols end up stressing some common issues. These include daily cessation of drugs to evaluate the patient and frequent reassessment of the level of sedation required by each specific patient.
Much is still unknown about the long-term effects of sedative and analgesic drugs used as infusions that may last from days to weeks to months. Hopefully, as more studies are performed, we will have more defined clinical end-points, newer drugs with rapid onset and offset and no active metabolites, and decreased morbidity and mortality for our patients.
Literature
1.
go back to reference Lewis KS, Whipple JK, Michael KA, et al. Effect of analgesic treatment on the physiological consequences of acute pain. Am J Hosp Pharm 1994; 51(12): 1539–54PubMed Lewis KS, Whipple JK, Michael KA, et al. Effect of analgesic treatment on the physiological consequences of acute pain. Am J Hosp Pharm 1994; 51(12): 1539–54PubMed
2.
go back to reference Mangano DT, Siliciano D, Hollenberg M, et al. Postoperative myocardial ischemia: therapeutic trials using intensive analgesia following surgery. Anesthesiology 1992; 76(3): 342–53PubMedCrossRef Mangano DT, Siliciano D, Hollenberg M, et al. Postoperative myocardial ischemia: therapeutic trials using intensive analgesia following surgery. Anesthesiology 1992; 76(3): 342–53PubMedCrossRef
3.
go back to reference Britton BJ, Hawkey C, Wood WG, et al. Stress: a significant factor in venous thrombosis? Br J Surg 1974; 61(10): 814–20PubMedCrossRef Britton BJ, Hawkey C, Wood WG, et al. Stress: a significant factor in venous thrombosis? Br J Surg 1974; 61(10): 814–20PubMedCrossRef
4.
go back to reference Slade MS, Greenberg LJ, Yunis EJ, et al. Integrated immune response to standard major surgical trauma in normal patients. Surg Forum 1974; 25: 425–7PubMed Slade MS, Greenberg LJ, Yunis EJ, et al. Integrated immune response to standard major surgical trauma in normal patients. Surg Forum 1974; 25: 425–7PubMed
5.
go back to reference Swinamer DL, Phang PT, Jones RL, et al. Effect of routine administration of analgesia on energy expenditure in critically ill patients. Chest 1988; 93(1): 4–10PubMedCrossRef Swinamer DL, Phang PT, Jones RL, et al. Effect of routine administration of analgesia on energy expenditure in critically ill patients. Chest 1988; 93(1): 4–10PubMedCrossRef
6.
go back to reference Moller IW, Dinesen K, Sondergard S, et al. Effect of patient-controlled analgesia on plasma catecholamine, cortisol and glucose concentrations after cholecystectomy. Br J Anaesth 1988; 61(2): 160–4PubMedCrossRef Moller IW, Dinesen K, Sondergard S, et al. Effect of patient-controlled analgesia on plasma catecholamine, cortisol and glucose concentrations after cholecystectomy. Br J Anaesth 1988; 61(2): 160–4PubMedCrossRef
7.
go back to reference Modig J, Borg T, Bagge L, et al. Role of extradural and of general anesthesia in fibrinolysis and coagulation after total hip replacement. Br J Anaesth 1983; 55: 625–9PubMedCrossRef Modig J, Borg T, Bagge L, et al. Role of extradural and of general anesthesia in fibrinolysis and coagulation after total hip replacement. Br J Anaesth 1983; 55: 625–9PubMedCrossRef
8.
go back to reference Salomaki TE, Leppaluoto J, Laitinen JO, et al. Epidural versus intravenous fentanyl for reducing hormonal, metabolic and physiologic responses after thoracotomy. Anesthesiology 1993; 79(4): 672–9PubMedCrossRef Salomaki TE, Leppaluoto J, Laitinen JO, et al. Epidural versus intravenous fentanyl for reducing hormonal, metabolic and physiologic responses after thoracotomy. Anesthesiology 1993; 79(4): 672–9PubMedCrossRef
9.
go back to reference Jones C, Griffiths RD, Macmillan RR, et al. Psychological problems occurring after intensive care. Br J Int Care 1994; 2: 46–53 Jones C, Griffiths RD, Macmillan RR, et al. Psychological problems occurring after intensive care. Br J Int Care 1994; 2: 46–53
10.
go back to reference Parker M, Schubert W, Shelhamer J, et al. Perceptions of a critically ill patient experiencing therapeutic paralysis in an ICU. Crit Care Med 1984; 12: 69–71PubMedCrossRef Parker M, Schubert W, Shelhamer J, et al. Perceptions of a critically ill patient experiencing therapeutic paralysis in an ICU. Crit Care Med 1984; 12: 69–71PubMedCrossRef
11.
go back to reference Stoll C, Haller M, Briegel J, et al. Health-related quality of life in long-term survivors after treatment with extracorporeal membrane oxygenation (ECMO) for the acute respiratory distress syndrome (ARDS). Anaesthesist 1998; 47(1): 24–9PubMedCrossRef Stoll C, Haller M, Briegel J, et al. Health-related quality of life in long-term survivors after treatment with extracorporeal membrane oxygenation (ECMO) for the acute respiratory distress syndrome (ARDS). Anaesthesist 1998; 47(1): 24–9PubMedCrossRef
13.
14.
go back to reference Ramsay MA, Savege TM, Simpson BR, et al. Controlled sedation with alphaxalone-alphadolone. BMJ 1974; 2(920): 656–9PubMedCrossRef Ramsay MA, Savege TM, Simpson BR, et al. Controlled sedation with alphaxalone-alphadolone. BMJ 1974; 2(920): 656–9PubMedCrossRef
15.
go back to reference Shapiro BA. Bispectral index: better information for sedation in the intensive care unit [editorial]? Crit Care Med 1999; 27(8): 1663–4PubMedCrossRef Shapiro BA. Bispectral index: better information for sedation in the intensive care unit [editorial]? Crit Care Med 1999; 27(8): 1663–4PubMedCrossRef
16.
go back to reference Glass PS, Bloom M, Kearse L, et al. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 1997; 86(4): 836–47PubMedCrossRef Glass PS, Bloom M, Kearse L, et al. Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 1997; 86(4): 836–47PubMedCrossRef
17.
go back to reference Liu J, Singh H, White PF. Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation. Anesth Analg 1997; 84(1): 185–9PubMed Liu J, Singh H, White PF. Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation. Anesth Analg 1997; 84(1): 185–9PubMed
18.
go back to reference Shah N, Clack S, Chea F, et al. Does bispectral index of EEG correlate with Ramsay sedation score in ICU patients [abstract]? Anesthesiology 1996; 85: A469 Shah N, Clack S, Chea F, et al. Does bispectral index of EEG correlate with Ramsay sedation score in ICU patients [abstract]? Anesthesiology 1996; 85: A469
19.
go back to reference Frenzel D, Greim C, Sommer C, et al. Is the bispectral index appropriate for monitoring the sedation level of mechanically ventilated surgical ICU patients? Intensive Care Med 2002; 28: 178–83PubMedCrossRef Frenzel D, Greim C, Sommer C, et al. Is the bispectral index appropriate for monitoring the sedation level of mechanically ventilated surgical ICU patients? Intensive Care Med 2002; 28: 178–83PubMedCrossRef
20.
go back to reference De Deyne C, Struys M, Decruyenaere J, et al. Use of continuous bispectral EEG monitoring to assess depth of sedation in ICU patients. Intensive Care Med 1998; 24(12): 1294–8PubMedCrossRef De Deyne C, Struys M, Decruyenaere J, et al. Use of continuous bispectral EEG monitoring to assess depth of sedation in ICU patients. Intensive Care Med 1998; 24(12): 1294–8PubMedCrossRef
21.
go back to reference Jacobi J, Fraser G, Coursin D, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30(1): 119–41PubMedCrossRef Jacobi J, Fraser G, Coursin D, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30(1): 119–41PubMedCrossRef
22.
go back to reference Hsu HO, Hickey RF, Forbes AR. Morphine decreases peripheral vascular resistance and increases capacitance in man. Anesthesiology 1979; 50(2): 98–102PubMedCrossRef Hsu HO, Hickey RF, Forbes AR. Morphine decreases peripheral vascular resistance and increases capacitance in man. Anesthesiology 1979; 50(2): 98–102PubMedCrossRef
23.
go back to reference Osborne R, Joel S, Slevin M. Morphine intoxication in renal failure: the role of morphine-6-glucuronide [letter]. BMJ (Clin Res Ed) 1986; 293(6554): 1101CrossRef Osborne R, Joel S, Slevin M. Morphine intoxication in renal failure: the role of morphine-6-glucuronide [letter]. BMJ (Clin Res Ed) 1986; 293(6554): 1101CrossRef
24.
go back to reference Stanley T, Webster L. Anesthetic requirements and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man. Anesth Analg 1978; 57: 411–6PubMed Stanley T, Webster L. Anesthetic requirements and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man. Anesth Analg 1978; 57: 411–6PubMed
25.
go back to reference Bodenham A, Shelly MP, Park GR. The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients. Clin Pharmacokinet 1988; 14(6): 347–73PubMedCrossRef Bodenham A, Shelly MP, Park GR. The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients. Clin Pharmacokinet 1988; 14(6): 347–73PubMedCrossRef
26.
go back to reference Haberer J, Schoeffler P, Courderc E, et al. Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. Br J Anaesth 1982; 54: 1267–70PubMedCrossRef Haberer J, Schoeffler P, Courderc E, et al. Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. Br J Anaesth 1982; 54: 1267–70PubMedCrossRef
27.
go back to reference Sarhill N, Walsh D, Nelson KA. Hydromorphone: pharmacology and clinical applications in cancer patients. Support Care Cancer 2001; 9(2): 84–96PubMedCrossRef Sarhill N, Walsh D, Nelson KA. Hydromorphone: pharmacology and clinical applications in cancer patients. Support Care Cancer 2001; 9(2): 84–96PubMedCrossRef
28.
go back to reference Zheng M, McErlane KM, Ong MC. Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient. Xenobiotica 2002; 32(5): 427–39PubMedCrossRef Zheng M, McErlane KM, Ong MC. Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient. Xenobiotica 2002; 32(5): 427–39PubMedCrossRef
29.
go back to reference Davis MP, Walsh D. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer 2001; 9(2): 73–83PubMedCrossRef Davis MP, Walsh D. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer 2001; 9(2): 73–83PubMedCrossRef
30.
go back to reference Felder C, Uehlinger C, Baumann P, et al. Oral and intravenous methadone use: some clinical and pharmacokinetic aspects. Drug Alcohol Depend 1999; 55(1–2): 137–43PubMedCrossRef Felder C, Uehlinger C, Baumann P, et al. Oral and intravenous methadone use: some clinical and pharmacokinetic aspects. Drug Alcohol Depend 1999; 55(1–2): 137–43PubMedCrossRef
31.
go back to reference Irifune M, Shimizu T, Nomoto M, et al. Ketamine-induced anesthesia involves the N-methyl-D-aspartate receptor-channel complex in mice. Brain Res 1992; 596(1–2): 1–9PubMedCrossRef Irifune M, Shimizu T, Nomoto M, et al. Ketamine-induced anesthesia involves the N-methyl-D-aspartate receptor-channel complex in mice. Brain Res 1992; 596(1–2): 1–9PubMedCrossRef
32.
go back to reference Gooding J, Dimick A, Tavakoli M, et al. A physiologic analysis of cardiopulmonary responses to ketamine anesthesia in non-cardiac patients. Anesth Analg 1977; 56: 813–6PubMed Gooding J, Dimick A, Tavakoli M, et al. A physiologic analysis of cardiopulmonary responses to ketamine anesthesia in non-cardiac patients. Anesth Analg 1977; 56: 813–6PubMed
33.
go back to reference Waxman K, Shoemaker W, Lippmann M. Cardiovascular effects of anesthetic induction with ketamine. Anesth Analg 1980; 59: 355–8PubMedCrossRef Waxman K, Shoemaker W, Lippmann M. Cardiovascular effects of anesthetic induction with ketamine. Anesth Analg 1980; 59: 355–8PubMedCrossRef
34.
go back to reference Joachimsson PO, Hedstrand U, Eklund A. Low-dose ketamine infusion for analgesia during postoperative ventilator treatment. Acta Anaesthesiol Scand 1986; 30(8): 697–702PubMedCrossRef Joachimsson PO, Hedstrand U, Eklund A. Low-dose ketamine infusion for analgesia during postoperative ventilator treatment. Acta Anaesthesiol Scand 1986; 30(8): 697–702PubMedCrossRef
35.
go back to reference Corssen G, Gutierrez J, Reves J, et al. Ketamine in the anesthetic management of asthmatic patients. Anesth Analg 1972; 51: 588–96PubMed Corssen G, Gutierrez J, Reves J, et al. Ketamine in the anesthetic management of asthmatic patients. Anesth Analg 1972; 51: 588–96PubMed
36.
go back to reference Chang T, Glazko A. Biotransformation and disposition of ketamine. Int Anesthesiol Clin 1974; 12: 157–77PubMedCrossRef Chang T, Glazko A. Biotransformation and disposition of ketamine. Int Anesthesiol Clin 1974; 12: 157–77PubMedCrossRef
37.
go back to reference Cohen IL. The management of the agitated ICU patient. Crit Care Med 2002; 30Suppl. 1: S97–123CrossRef Cohen IL. The management of the agitated ICU patient. Crit Care Med 2002; 30Suppl. 1: S97–123CrossRef
38.
go back to reference Greenblatt DJ, Shader RI, Franke K, et al. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci 1979; 68(1): 57–63PubMedCrossRef Greenblatt DJ, Shader RI, Franke K, et al. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci 1979; 68(1): 57–63PubMedCrossRef
39.
go back to reference Pohlman AS, Simpson KP, Hall JB. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study. Crit Care Med 1994; 22(8): 1241–7PubMedCrossRef Pohlman AS, Simpson KP, Hall JB. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study. Crit Care Med 1994; 22(8): 1241–7PubMedCrossRef
40.
go back to reference Laine GA, Hossain SMH, Solis RT, et al. Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam. Ann Pharmacother 1995; 29(11): 1110–4PubMed Laine GA, Hossain SMH, Solis RT, et al. Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam. Ann Pharmacother 1995; 29(11): 1110–4PubMed
41.
go back to reference Cawley MJ. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacotherapy 2001; 21(9): 1140–4PubMedCrossRef Cawley MJ. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacotherapy 2001; 21(9): 1140–4PubMedCrossRef
43.
go back to reference Greenblatt D, Shader R, Harmatz J. Benzodiazepines: a summary of pharmacokinetic properties. Br J Clin Pharmacol 1981; 11: 11–6CrossRef Greenblatt D, Shader R, Harmatz J. Benzodiazepines: a summary of pharmacokinetic properties. Br J Clin Pharmacol 1981; 11: 11–6CrossRef
44.
go back to reference Adams P, Gelman S, Reves JG, et al. Midazolam pharmacodynamics and pharmacokinetics during acute hypovolemia. Anesthesiology 1985; 63(2): 140–6PubMedCrossRef Adams P, Gelman S, Reves JG, et al. Midazolam pharmacodynamics and pharmacokinetics during acute hypovolemia. Anesthesiology 1985; 63(2): 140–6PubMedCrossRef
45.
go back to reference Malacrida R, Fritz ME, Suter PM, et al. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 1992; 20(8): 1123–6PubMedCrossRef Malacrida R, Fritz ME, Suter PM, et al. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 1992; 20(8): 1123–6PubMedCrossRef
46.
go back to reference Hall R, Zisook S. Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol 1981; 11: 99S–104SPubMedCrossRef Hall R, Zisook S. Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol 1981; 11: 99S–104SPubMedCrossRef
47.
go back to reference Dirksen MS, Vree TB, Driessen JJ. Clinical pharmacokinetics of long-term infusion of midazolam in critically ill patients: preliminary results. Anaesth Intensive Care 1987; 15(4): 440–4PubMed Dirksen MS, Vree TB, Driessen JJ. Clinical pharmacokinetics of long-term infusion of midazolam in critically ill patients: preliminary results. Anaesth Intensive Care 1987; 15(4): 440–4PubMed
48.
go back to reference Reves JG, Fragen RJ, Vinik R, et al. Midazolam pharmacology and uses. Anesthesiology 1985; 62(3): 310–24PubMedCrossRef Reves JG, Fragen RJ, Vinik R, et al. Midazolam pharmacology and uses. Anesthesiology 1985; 62(3): 310–24PubMedCrossRef
49.
go back to reference Mandema JW, Tuk B, Van Steveninck AL, et al. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther 1992; 51(6): 715–28PubMedCrossRef Mandema JW, Tuk B, Van Steveninck AL, et al. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther 1992; 51(6): 715–28PubMedCrossRef
50.
go back to reference Hamaoka N, Oda Y, Hase I, et al. Propofol decreases the clearance of midazolam by inhibiting CYP3A4: in vivo and in vitro study [abstract]. Anesthesiology 1999; 91(3A): A451 Hamaoka N, Oda Y, Hase I, et al. Propofol decreases the clearance of midazolam by inhibiting CYP3A4: in vivo and in vitro study [abstract]. Anesthesiology 1999; 91(3A): A451
51.
go back to reference Ahonen J, Olkkola KT, Salmenpera M, et al. Effect of diltiazem on midazolam and alfentanil disposition in patients undergoing coronary artery bypass grafting. Anesthesiology 1996; 85(6): 1246–52PubMedCrossRef Ahonen J, Olkkola KT, Salmenpera M, et al. Effect of diltiazem on midazolam and alfentanil disposition in patients undergoing coronary artery bypass grafting. Anesthesiology 1996; 85(6): 1246–52PubMedCrossRef
52.
go back to reference Ariano RE, Kassum DA, Aronson KJ. Comparison of sedative recovery time after midazolam versus diazepam administration. Crit Care Med 1994; 22(9): 1492–6PubMedCrossRef Ariano RE, Kassum DA, Aronson KJ. Comparison of sedative recovery time after midazolam versus diazepam administration. Crit Care Med 1994; 22(9): 1492–6PubMedCrossRef
53.
go back to reference Klotz I, Avant G, Hoyumpa A, et al. The effects of age and liver disease on the disposition and elimination of diazepam in adult man [abstract]. J Clin Invest 1975; 55: 347PubMedCrossRef Klotz I, Avant G, Hoyumpa A, et al. The effects of age and liver disease on the disposition and elimination of diazepam in adult man [abstract]. J Clin Invest 1975; 55: 347PubMedCrossRef
54.
go back to reference Barr J, Egan TD, Sandoval NF, et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 2001; 95(2): 324–33PubMedCrossRef Barr J, Egan TD, Sandoval NF, et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 2001; 95(2): 324–33PubMedCrossRef
55.
go back to reference Fulton B, Sorkin EM. Propofol: an overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995; 50(4): 636–57PubMedCrossRef Fulton B, Sorkin EM. Propofol: an overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995; 50(4): 636–57PubMedCrossRef
56.
go back to reference McLeod G, Dick J, Wallis C, et al. Propofol 2 percent in critically ill patients: effect on lipids. Crit Care Med 1997; 25(12): 1976–81PubMedCrossRef McLeod G, Dick J, Wallis C, et al. Propofol 2 percent in critically ill patients: effect on lipids. Crit Care Med 1997; 25(12): 1976–81PubMedCrossRef
57.
go back to reference Possidente C, Rogers F, Osier T, et al. Elevated pancreatic enzymes after extended propofol therapy. Pharmacotherapy 1998; 18: 653–5PubMed Possidente C, Rogers F, Osier T, et al. Elevated pancreatic enzymes after extended propofol therapy. Pharmacotherapy 1998; 18: 653–5PubMed
58.
go back to reference Badr AE, Mychaskiw II G, Eichhorn JH. Metabolic acidosis associated with a new formulation of propofol. Anesthesiology 2001; 94(3): 536–8PubMedCrossRef Badr AE, Mychaskiw II G, Eichhorn JH. Metabolic acidosis associated with a new formulation of propofol. Anesthesiology 2001; 94(3): 536–8PubMedCrossRef
59.
go back to reference Cremer OL, Moons KG, Bouman EA, et al. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001; 357(9250): 117–8PubMedCrossRef Cremer OL, Moons KG, Bouman EA, et al. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001; 357(9250): 117–8PubMedCrossRef
60.
go back to reference Veroli P, O’Kelly B, Bertrand F, et al. Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation. Br J Anaesth 1992; 68(2): 183–6PubMedCrossRef Veroli P, O’Kelly B, Bertrand F, et al. Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation. Br J Anaesth 1992; 68(2): 183–6PubMedCrossRef
61.
go back to reference Morcos WE, Payne JP. The induction of anaesthesia with propofol (‘Diprivan’) compared in normal and renal failure patients. Postgrad Med J 1985; 61 Suppl. 3: 62–3PubMed Morcos WE, Payne JP. The induction of anaesthesia with propofol (‘Diprivan’) compared in normal and renal failure patients. Postgrad Med J 1985; 61 Suppl. 3: 62–3PubMed
62.
go back to reference Fish DN. Treatment of delirium in the critically ill patient. Clin Pharm 1991; 10(6): 456–66PubMed Fish DN. Treatment of delirium in the critically ill patient. Clin Pharm 1991; 10(6): 456–66PubMed
63.
go back to reference Tesar G, Murray G, Cassem N, et al. Use of haloperidol for acute delirium in intensive care setting. J Clin Psychopharmacol 1985; 5: 344–7PubMed Tesar G, Murray G, Cassem N, et al. Use of haloperidol for acute delirium in intensive care setting. J Clin Psychopharmacol 1985; 5: 344–7PubMed
64.
go back to reference Sharma N, Rosman H, Padhi D, et al. Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998; 81: 238–40PubMedCrossRef Sharma N, Rosman H, Padhi D, et al. Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998; 81: 238–40PubMedCrossRef
65.
66.
go back to reference Belleville JP, Ward DS, Bloor BC, et al. Effects of intravenous dexmedetomidine in humans: I, sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77(6): 1125–33PubMedCrossRef Belleville JP, Ward DS, Bloor BC, et al. Effects of intravenous dexmedetomidine in humans: I, sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77(6): 1125–33PubMedCrossRef
67.
go back to reference Scheinin B, Lindgren L, Randell T, et al. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. Br J Anaesth 1992; 68(2): 126–31PubMedCrossRef Scheinin B, Lindgren L, Randell T, et al. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. Br J Anaesth 1992; 68(2): 126–31PubMedCrossRef
68.
go back to reference Venn R, Bradshaw C, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a bovel agent for postoeprative sedation in the intensive care unit. Anesthesia 1999; 54: 1136–42CrossRef Venn R, Bradshaw C, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a bovel agent for postoeprative sedation in the intensive care unit. Anesthesia 1999; 54: 1136–42CrossRef
70.
go back to reference Soliman H, Melot C, Vincent J. Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth 2001; 87(2): 186–92PubMedCrossRef Soliman H, Melot C, Vincent J. Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth 2001; 87(2): 186–92PubMedCrossRef
71.
go back to reference Christensen BV, Thunedborg LP. Use of sedatives, analgesics and neuromuscular blocking agents in Danish ICUs 1996/97: a national survey. Intensive Care Med 1999; 25(2): 186–91PubMedCrossRef Christensen BV, Thunedborg LP. Use of sedatives, analgesics and neuromuscular blocking agents in Danish ICUs 1996/97: a national survey. Intensive Care Med 1999; 25(2): 186–91PubMedCrossRef
72.
go back to reference Murdoch S, Cohen A. Intensive care sedation: a review of current British practice. Intensive Care Med 2000; 26(7): 922–8PubMedCrossRef Murdoch S, Cohen A. Intensive care sedation: a review of current British practice. Intensive Care Med 2000; 26(7): 922–8PubMedCrossRef
73.
go back to reference Shapiro BA, Warren J, Egol AB, et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary: Society of Critical Care Medicine. Critical Care Med 1995; 23(9): 1596–600CrossRef Shapiro BA, Warren J, Egol AB, et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary: Society of Critical Care Medicine. Critical Care Med 1995; 23(9): 1596–600CrossRef
74.
go back to reference Ely EW, Baker AM, Dunagan DP, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996; 335(25): 1864–9PubMedCrossRef Ely EW, Baker AM, Dunagan DP, et al. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996; 335(25): 1864–9PubMedCrossRef
75.
go back to reference Brook AD, Ahrens TS, Schaiff R, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27(12): 2609–15PubMedCrossRef Brook AD, Ahrens TS, Schaiff R, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27(12): 2609–15PubMedCrossRef
76.
go back to reference Kress JP, Pohlman AS, O’Connor MF, et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342(20): 1471–7PubMedCrossRef Kress JP, Pohlman AS, O’Connor MF, et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342(20): 1471–7PubMedCrossRef
Metadata
Title
Postoperative Analgesia and Sedation in the Adult Intensive Care Unit
A Guide to Drug Selection
Authors
Assistant Clinical Professor Linda L. Liu
Michael A. Gropper
Publication date
01-04-2003
Publisher
Springer International Publishing
Published in
Drugs / Issue 8/2003
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200363080-00003

Other articles of this Issue 8/2003

Drugs 8/2003 Go to the issue

Adis Drug Evaluation

Lopinavir/Ritonavir

Adis Drug Evaluation

Rituximab